ASCP explores the cancer biomarker testing navigator as a novel role to improve laboratory operations and workflows: A special report from the ASCP Biomarker Testing Navigator Project Team. [PDF]
Pineault L+11 more
europepmc +1 more source
Optimization of oncology biomarker testing in managed care: Best practices and consensus recommendations from an AMCP Market Insights program. [PDF]
Brixner D+9 more
europepmc +1 more source
Interpreting results from biomarker-guided clinical trials: avoiding "negative" or "failed" terminology. [PDF]
Noor NM+7 more
europepmc +1 more source
Multivariable Modeling of Postoperative Risk in Infant Cardiac Surgery: Integrating Clinical Variables and 20 Inflammatory Biomarkers. [PDF]
Kvaran RB+10 more
europepmc +1 more source
Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non-Small Cell Lung Cancer (LIQUIK). [PDF]
Samol J+12 more
europepmc +1 more source
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
S. Patel, R. Kurzrock
semanticscholar +1 more source
Advances in Circulating Biomarkers for Neurodegenerative Diseases, Traumatic Brain Injuries, and Central Nervous System Tumors. [PDF]
Yang M, Zhang A, Chen M, Cao J.
europepmc +1 more source
Exploring Cancer Patients' and Caregivers' Perspectives and Knowledge Regarding Biomarker Testing in Canada. [PDF]
Mksyartinian P+4 more
europepmc +1 more source
Correction: Expression of genes with biomarker potential identified in skin from DSLD-affected horses increases with age. [PDF]
Roberts JH+6 more
europepmc +1 more source
Computational Risk Stratification of Preclinical Alzheimer's in Younger Adults. [PDF]
Anyaiwe O, Nataraj N, Gudikandula BS.
europepmc +1 more source